MS-STAT2 information

MS-STAT2 is a phase 3 clinical trial that will test the benefits of simvastatin for people with secondary progressive MS.

Recruitment for the trial isn't open yet, but we expect it to begin in November 2017. If you'd like us to let you know when you can register an interest, please leave your details below.

By providing your details you agree for us to contact you with information about how you can register an interest in MS-STAT2 when recruitment opens. If you change your mind and no longer want us to hear from us about the trial please email us or call 0300 500 8084.

Your details are safe with us. We will never give them away, sell them or swap them with anyone else. We will delete this data after you have been contacted.

You can view our privacy notice here.

What's new?